MedPath

Efficacy of Cyclosporine Ophthalmic Emulsion in the Treatment of Dry Eye Syndrome in Contact Lens Wearers

Not Applicable
Completed
Conditions
Contact Lens Wearers With Dry Eye Syndrome
Registration Number
NCT00335114
Lead Sponsor
University of Alabama at Birmingham
Brief Summary

Cyclosporine Ophthalmic Emulsion is currently used in the treatment of dry eye syndrome. Contact lens wearers frequently suffer from dry eye syndrome. The purpose of this study is to evaluate cyclosporine ophthalmic emulsion verses re-wetting drops in the relief of dry eye symptoms in contact lens wearers

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • contact lens wearer
  • clinical diagnosis of dry eye syndrome
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Ocular exams and questionnaires at baseline and at 3 months will determine
the effect of cyclosporine on dry eye syndrome.
Secondary Outcome Measures
NameTimeMethod
of dry eye symptoms
Increased contact lens wearing time due to a decrease in severity

Trial Locations

Locations (1)

UAB Ophthalmology Services Foundation

🇺🇸

Birmingham, Alabama, United States

© Copyright 2025. All Rights Reserved by MedPath